Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure

PURPOSE: Tocilizumab has been shown to decrease mortality when used concomitantly with steroids in COVID-19 with 8 mg/kg (max 800 mg) being the standard dose. Our study sought to assess whether a low dose (400 mg) shows similar benefit compared to a high dose for COVID patients concurrently on the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Juri, Brosnahan, Shari B., Islam, Shahidul, Altshuler, Diana, Spiegler, Peter, Li, Wai Kin, Wang, Wai Man, Chen, Xian Jie Cindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084735/
https://www.ncbi.nlm.nih.gov/pubmed/37043893
http://dx.doi.org/10.1016/j.jcrc.2023.154291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084735/
https://www.ncbi.nlm.nih.gov/pubmed/37043893
http://dx.doi.org/10.1016/j.jcrc.2023.154291

Ejemplares similares